Risk Behaviour, Health Care Access and Prevalence of infection with Chlamydia trachomatis and Neisseria gonorrhoea in a population based sample of.

Slides:



Advertisements
Similar presentations
PREVALENCE OF CHLAMYDIA TRACHOMATIS, NEISSERIA GONORRHOEAE AND TRICHOMONAS VAGINALIS IN YOUNG WOMEN IN KENYA USING THE GEN-PROBE APTIMA ASSAYS J Moncada.
Advertisements

Sexually Transmitted Diseases
An introduction to sexual health screening for Health Care Assistants
Field Based Treatment of Chlamydia and Gonorrhea Nilmarie Guzmán,MD & Michael Sands,MD University of Florida/Jacksonville and the Duval County Health Department.
Self-Collected Vaginal Specimens for the Detection of Multiple STIs in Adolescent Detainees Cynthia M. Holland, M.D., M.P.H., Harold C. Wiesenfeld, M.D.,
Epidemiology of Chlamydia in the United States Debra J. Mosure, Ph.D. Division of STD Prevention Centers for Disease Control and Prevention March 8, 2004.
 Definition  Signs and Symptoms › Males and females  How it’s transmitted  How it’s diagnosed  Treatment  Complications if not treated  Prevention.
BATERIA/VIRUSES.! CHLAMYDIA BY: ASHLEY FROST, JUANA GUZAMN & FINESSE MATOS.
Chlamydia trachomatis testing Research Center for Genetic Engineering and Biotechnology “Georgi D. Efremov”, MASA What is Chlamydia trachomatis? Chlamydia.
CHLAMYDIA.
Gonorrhea is a sexually transmitted disease
 By: Parminder, Elvin, Gardy and Kim.  Chlamydia is a disease caused by the bacteria called Chlamydia trachomatis. It is mostly commonly sexually transmitted.
Adult Medical-Surgical Nursing
Swedish GP training presentation in English
KNOW HIV/STD Prevention Curriculum Grade 8 Lesson 2
Sexual Transmitted Diseases
RTI International is a trade name of Research Triangle Institute Untreated chlamydial infection among adolescents and young adults in Baltimore,
STD’s What you need to know Sexuality PowerPoint 4.6.
Sexually Transmitted Infections STI’s or STDs (Sexually Transmitted Diseases)
Natalia Larrañaga Sara María Becerra. What are they? Sexually transmitted diseases (also known as STD´s) are infectious diseases that spread from person.
PID Normal Human Fallopian Tube Tissue C. trachomatis Infection (PID)
Sexually Transmitted Diseases (STI’s) Chlaymadia/syphillys
Sexually Transimitted Diseases. Gonorrhea Cause –bacteria (Neisseria gonorrhoeae) Mode of transfer –Primary infection site is in cervix from intercourse.
Evaluation of Presumptive Treatment Recommendation for Asymptomatic Anorectal Gonorrhoea and Chlamydia Infections in At-Risk Kenyan MSM IAS 24 July 2012.
High School Reproductive System Disease Presentation HCA240 Gonorrhea.
By: Hayley MacDonald and Morgan Dolak
STDs in Adolescents and Young Adults Sexually Transmitted Disease Surveillance 2005 Division of STD Prevention.
GONORRHEA OLIVIA PEREZ & JAYSON HELMES SENIOR HEALTH 12 BLOCK 2B MARCH 2016.
Control & prevention OFS.T.I. ALI ASGHAR FARAZI MD. MPH.
The Dublin Well Woman Centre and The National Virus Reference Laboratory  Approved by ICGP Ethics Committee.
Rodney C. Perkins 1, Grace K. Douglass 2, Victoria C. Ta 2, Aurnell Dright 1, Michael Fomundam 2, Ying Li 3, Michael Plankey 3 Sexually Transmitted Infection.
Human Immunodeficiency Virus Infection among Patients with Sexually Transmitted Infections in Zimbabwe: More Mungati: MBChB, MPH Zimbabwe Ministry.
CHLAMYDIA TRACHOMATIS – DIAGNOSIS AND MANAGEMENT Jess Gaddie (adapted from presentation by Rachel Coyne)
How to get rid of Gonorrhea
Gonorrhea STD Science Fair Project Group Members: Tiffany Jackson, Rachel Roessel, Siobhan Murphy.
Herpes Simplex Virus Type 2 infections in Germany : Results of a nationwide seroprevalence survey Dr. Gerit Solveig Korr, MSc DTMH IUSTI, Marrakech,
How can Health Care Assistants & Practice Nurses increase STI & HIV screening in primary care Dr Jane Hutchinson 5 th March 2015.
Seeking HIV-testing Only: Missed Opportunity for HIV Prevention?
Vaginal Swabs Clinical Information Why? Murray Robinson
Rectal chlamydia infection in women Have we been missing the point?
J. Mossong1, N. Majéry2, C. Mardaga3 , M. Muller4, F. Schneider1
Sexually Transmitted Infections
SEXUALLY TRANSMITTED INFECTIONS
Xth International Conference on AIDS and STD in Africa, December 1997
Mycoplasma genitalium and macrolide resistance in pelvic inflammatory disease (PID) Gillian Dean1, Jennifer Whetham1, Suneeta Soni1, Rachel Pitt2, Sarah.
*Aminu Maryam and Ejiogu C. Nkechi
1University of Kentucky, Lexington, Kentucky
Topic Gonorrhea Diseases
Prevalence of Sexually Transmitted Infections and Bacterial Vaginosis among Female Adolescents in the United States: Data from the National Health and.
Gonorrhoea & PID PHCP 402 By K S Labaran.
Xth International Conference on AIDS and STD in Africa, December 1997
It's not what you know, but who you know: Risk factors for re-infection in the Philadelphia High School STD Screening Program Jennifer Beck, MPH APHA.
Sexually Transmitted Infections (STIs) in Ireland: Q1-Q2, 2017
Sexual Health in Primary Care
Bell Ringer Why would teens need to be concerned about STDs?
Sexually Transimitted Diseases
Non-Viral STD of Major significance
AIDS- Acquired Immune Deficiency Syndrome /Gonorrhoea
Current STD Testing and Treatment Guidelines
Only YES means YES. How or with whom—it’s up to us
Sexually Transmitted Diseases (STDs) Non-Viral
Health Protection Surveillance Centre
STDs vs. STIs What’s the difference? Why?
Sexually Transmitted Diseases Overview (STDs)
Reproductive Systems Mini REVIEW
By Abhi ,Jenny, Akanksha, Sanat, Sriya, Sushmitha, Mariam,Digveer,
Finding Sex Partners On-Line: What’s the Risk for STI
Forest plot of various sensitivity analyses of the risk for pelvic inflammatory disease (PID), ectopic pregnancy and tubal factor infertility (TFI) between.
Presentation transcript:

Risk Behaviour, Health Care Access and Prevalence of infection with Chlamydia trachomatis and Neisseria gonorrhoea in a population based sample of adults in Barbados O.P. Adams, G. McIntyre, P. Prussia The University of the West Indies, Cave Hill, Barbados

Objectives To determine the prevalence of urogenital infection with Chlamydia trachomatis and Neisseria gonorrhoea in persons 18 to 35 years of age

Objectives To determine factors that could be used to identify infected persons Risk factors Health Care Access Symptoms

Why Do This Study? Infection with CT and NG have important health consequences especially for females Pelvic inflammatory Disease Ectopic pregnancy Infertility

Why Do This Study? Males may have Epididymitis Urethral strictures Newborns may have Conjuctivitis Pneumonia

Why Do This Study? Non-ulcerative Sexually Transmitted Infections may enhance the spread of HIV

Why Do This Study? Little was known about the prevalence of NG and CT in Barbados Previous studies have used selected clinic populations No published study has been done on a population based sample, or on males

Previous Studies - Barbados Attapatu, Levett et al; 1999 Barbados 11.4% prevalence of asymptomatic chlamydia in women attending an O+G clinic Rollock et al; 2002 SWSPC 9.8% prevalence in women attending an antenatal clinic with a 20.8% prevalence in 15 to 19 year olds

Method Random sample of 18 to 35 year persons living in the St. Michael South East Electoral District Questionnaire administered privately Urine collected Urine tested by PCR using the Roche Amplicor kit

Results 440 persons approached -216 males and 224 females 382 persons (86.8%) responded -179 males and 203 females 321 had urine tests completed by laboratory - 151 males and 170 females

Usual source of Health Care

Time last seen by Doctor %

Age at sexual debut %

Condom use Last intercourse with non-regular partner no 118 persons yes 119 persons no 118 persons No difference in prevalence of infection between the 2 groups (p=.515)

Knowledge Heard of chlamydia yes 29.4% (95%CI +4.9) no 70.6% (95%CI +4.9) Heard of gonorrhoea yes 91.6% (95%CI +3.0) no 8.4% (95%CI +3.0)

Chlamydia and Gonorrhoea Prevalence NG +/or CT positive 14.3% (95%CI 10.5-18.2) NG positive 2.2% (95%CI 0.6-3.8) CT positive 12.8% (95%CI 9.1-16.4)

Prevalence of Chlamydia and Gonorrhoea % Test result

Prevalence by Age group 18 to 20 years of age (n=72) 26.4% (95%CI +10.0) 21 to 35 years of age (n=248) 10.9% (95% CI +3.8) (p = .001)

Prevalence by Age group

Urethral discharge (males) STD status No discharge Mild discharge Moderate discharge negative N (%) 123 (96.9%) 3 (2.4%) 1 (0.8%) positive 18 (94.7) (5.3%)

Vaginal discharge STD status negative N (%) 118 (84.3%) 16 (11.4%) 6 No discharge Mild discharge Mod/severe discharge negative N (%) 118 (84.3%) 16 (11.4%) 6 (4.3%) positive 24 (88.9%) 1 (3.7%) 2 (7.4)

Number (%) without symptom STD status Abdominal pain Dyspraeunia Inter-menstrual bleed negative N (%) 127 (90.7%) 124 (89.9%) 126 (90.6%) positive 21 (80.8%) 24 (92.3%) (80.8)

Symptoms Baltimore study < 5% of infected participants reported dysuria or genital discharge. Handsfield 1974 Study of 2628 enlisted men Gonnorhoea was detected in 59 men (2.2%) 40 of these asymptomatic

Summary There is a high prevalence of urogenital Chlamydia trachomatis in both males and females in Barbados Young persons have an extremely high prevalence of CT Symptoms are neither sensitive or specific for the identification of infection

Summary Most persons have never heard of chlamydia

Recommendations Routine screening should be introduced especially for chlamydia in adults 18 to 20 years of age. A similar study is needed for children 16 to 17 years of age.

Recommendations Health care professionals and the public should be sensitised both to the prevalence and consequence of infection with chlamydia trachomatis.

Acknowledgements Funding CHRC Pfizer Roche Laboratory testing facilitated by the Ministry of Health, Barbados

Acknowledgements Data collection Cynthia Clarke Data entry Maxine Hinds Laboratory testing N. Adomakoh, A. Abayomi, S. Branch and other staff of the Lady Meade Reference Unit